Medications for Diabetic Retinopathy

5 results
  • cimerli - ranibizumab - eqrn injection, solution

    (Ranibizumab-Eqrn)
    Coherus Biosciences Inc
    Cimerli treats neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.
  • eylea hd - aflibercept injection, solution

    (Aflibercept)
    Regeneron Pharmaceuticals, Inc
    EYLEA HD treats neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME), diabetic retinopathy (DR), and macular edema following retinal vein occlusion (RVO).
  • iluvien - fluocinolone acetonide implant

    (Fluocinolone Acetonide)
    Alimera Sciences, Inc.
    ILUVIEN is a corticosteroid implant indicated for diabetic macular edema (DME) in patients previously treated with corticosteroids without significant intraocular pressure increase, and for chronic non-infectious uveitis affecting the posterior segment of the eye.
  • lucentis - ranibizumab injection, solution

    (Ranibizumab)
    Genentech, Inc.
    Lucentis treats neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.
  • susvimo - ranibizumab injection, solution

    (Ranibizumab)
    Genentech, Inc.
    Susvimo (ranibizumab) treats neovascular (wet) age-related macular degeneration, diabetic macular edema, and diabetic retinopathy in patients who have previously responded to at least two intravitreal VEGF inhibitor injections.